New regulatory affairs VP at MonoSol Rx
This article was originally published in SRA
Executive Summary
MonoSol Rx, a US-based pharmaceutical company specialising in film drug delivery, has appointed Mary Ellen Norvitch to the newly created position of vice president of regulatory affairs, clinical affairs and quality assurance. Dr Norvitch was most recently vice president of US regulatory affairs at ProStrakan.